Director of Operations Finance, Cellares
$170-240k
+ Stock options
Office located in Bridgewater, NJ
Cell therapy manufacturing services provider
Open for applications
Cell therapy manufacturing services provider
201-500 employees
Open for applications
$170-240k
+ Stock options
Office located in Bridgewater, NJ
201-500 employees
Company mission
To accelrete access to life-saving cell therapies.
Role
Who you are
- Top candidates will be intellectually curious, detail-oriented, and able to collaboratively drive solutions to complex problems
- This is a hands-on role with a scaling early-stage company, and the ability to drive the performance of the organization through financial insights and foresight is critical to our success
- Candidates should enjoy working in a fast-paced, mission-driven environment and be prepared to tackle a broad selection of challenges as the company grows
- Bachelor’s degree in finance, accounting, or a related field
- 10+ years of relevant demonstrated financial and leadership experience
- Extensive experience with SAP or other relevant ERP solutions
- Experience with analysis tools and databases such as SQL, Power Query, Power BI, Snowflake, and Tableau
- Highly organized with a meticulous attention to detail and the willingness to be in a hands-on position
- Deep understanding of industry financials
- Proven track record of financial leadership in a fast-paced, dynamic environment
- Strong analytical and problem-solving skills, with the ability to synthesize complex information into clear recommendations
- Excellent communication and interpersonal skills, with the ability to work effectively with both internal teams and external partners
What the job involves
- Cellares is seeking a dynamic, influential, and highly motivated Director, Operations Finance with extensive FP&A, accounting, manufacturing, supply chain, and business partnering experience with a track record of success, who will contribute significantly to driving our organization forward to achieve our ambitious goals
- The primary focus of this position will be to support the Operations organization worldwide, including our manufacturing sites in Bridgewater, NJ, Europe, and Japan
- This position will be responsible for product costing and driving operational efficiencies to improve gross margin
- They will also lead the cost forecast process for assets under development and new products in the commercial pipeline
- They will be directly responsible for leading the finance teams at our manufacturing facilities worldwide
- Work collaboratively with the Chief Operating Officer and Operations leadership to provide financial support and business partnering for the Operations organization
- Manage all aspects of FP&A for Operations, such as forecasting, monthly budget vs. actual, and analysis
- Provide insights into key opportunities and profitability for potential projects to ensure each is financially viable and aligns with the company’s strategic goals
- Develop and maintain the manning plan for our manufacturing sites to ensure gross margin targets are achieved and drive cost improvement projects to improve gross margins over time
- Support the creation of business and financial presentations (e.g., board decks, Quarterly Business Reports, etc.) for Operations-related activities
- Establish and lead Operations Finance teams at our manufacturing site in Bridgewater, Europe, and Japan
- As part of the Company’s annual audit process, prepare supporting and supplemental information as requested by the Company’s auditors, as it relates to Operations
Our take
There is a significant need for efficient, scalable manufacturing of cell therapies in the biopharmaceutical industry. As demand for advanced treatments like CAR T-cell therapies rises, traditional manufacturing methods often struggle with scalability, high costs, and process failures, limiting patients' access to these lifesaving therapies.
In response, Cellares has developed the CEll Shuttle platform, an automated system designed for high-throughput cell therapy production. The Cell Shuttle can manufacture 16 batches simultaneously, cutting batch costs by up to 50%. By integrating advanced technologies for flow cytometry and cell sorting, Cellares enhances operational efficiency, providing comprehensive solutions that accelerate access to therapies.
Partnering with industry leaders like Kite, Bristol Myers Squibb, and Cabeletta Bio further strengthens its market position, showcasing the platform's potential impact. Along with over $355M in funding and a commercial-scale facility in New Jersey, Cellares is well-prepared to scale operations and meet global demand, positioning itself for future growth in the evolving cell therapy landscape.
Steph
Company Specialist at Welcome to the Jungle
Insights
44% employee growth in 12 months
Company
Funding (last 2 of 3 rounds)
Aug 2023
$255m
SERIES C
May 2021
$82m
SERIES B
Total funding: $355m
Company benefits
- Holidays & Flexible Vacation
- Parental Leave
- Comprehensive Healthcare
- 401k + Company Match
- Catered Onsite Meals
- Premium Technology
- EV Charging
- Professional Development
Company HQ
The East Side, South San Francisco, CA
Leadership
Fabian Gerlinghaus
(Co-Founder & CEO)Graduated from the University of Munich with a Master's Degree in Aerospace Engineering. Prior to co-founding Cellares in 2019, they were the CHief Innovation officer at Synthego.
Salary benchmarks
We don't have enough data yet to provide salary benchmarks for this role.
Submit your salary to help other candidates with crowdsourced salary estimates.
Share this job
View 5 more jobs at Cellares